Vestcor Inc’s Corbus Pharmaceuticals CRBP Stock Holding History

Vestcor Inc’s Portfolio CRBP Stock Details CRBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-3,100	Closed	-$37K	–	1185
2024 Q4	$37K	Hold	3,100	–	–	﹤0.01%	1144
2024 Q3	$64K	Buy	+3,100	New	+$159K	﹤0.01%	1087

Other funds holding CRBP

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

EAM

Exome Asset Management New York $193M AUM 208.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vestcor Inc's CRBP Position: Q1 2025 in Review

Vestcor Inc sold out of Corbus Pharmaceuticals (CRBP) in Q1 2025, closing a stake of 3,100 shares — an estimated $37K sold.

Vestcor Inc first reported a position in CRBP in Q3 2024 and held it in 2 quarters. The position peaked at $64K in Q3 2024. 86 funds tracked by Wall St. Rank hold CRBP as of Q1 2025.

Vestcor Inc reported no remaining Corbus Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
Vestcor Inc sold 3,100 Corbus Pharmaceuticals shares in Q1 2025, an estimated $37K.
Vestcor Inc first reported a position in Corbus Pharmaceuticals in Q3 2024 and held it in 2 quarters.
Vestcor Inc's Corbus Pharmaceuticals position peaked at $64K in Q3 2024.
86 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q1 2025.

Based on Vestcor Inc's 13F filing for Q1 2025, filed 8 May 2025.